The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Indole, a core nucleus for potent inhibitors of tubulin polymerization
Abstract
Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti‐cancer therapy. Several tubulin polymerization inhibitors characterized by the presence of an indole nucleus have been obtained from natural sources or have been prepared by semi‐synthesis. In the last decade an ever increasing number of synthetic indoles have been reported. We have reviewed anti‐tubulin agents obtained by synthesis having an indole as core nucleus. The synthesis, the biological activity, and the structure–activity relationship aspects of 3‐formyl‐2‐phenylindoles, heterocombretastatins, diarylindoles, 2‐aroylindoles, D‐24851, 2‐aryl‐3‐aroylindoles, 3‐aroyl‐ and 1‐aroylindoles, and arylthioindoles are discussed. © 2006 Wiley Periodicals, Inc. Med Res Rev
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
Ravelli, R. B. G., Gigant, B., Curmi, P. A., Jourdain, I., Lachkar, S., Sobel, A., & Knossow, M. (2004) · Nature · doi:10.1038/nature02393 · Cited by 1,630
Mechanism of Action of Antitumor Drugs that Interact with Microtubules and Tubulin
Jordan, M. (2012) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011023354290 · Cited by 775
Höfle, G., Bedorf, N., Steinmetz, H., Schomburg, D., Gerth, K., & Reichenbach, H. (1996) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199615671 · Cited by 515
D'Amato, R. J., Lin, C. M., Flynn, E., Folkman, J., & Hamel, E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3964 · Cited by 406
Discodermolide, A Cytotoxic Marine Agent That Stabilizes Microtubules More Potently Than Taxol,
ter Haar, E., Kowalski, R. J., Hamel, E., Lin, C. M., Longley, R. E., Gunasekera, S. P., Rosenkranz, H. S., & Day, B. W. (1996) · Biochemistry · doi:10.1021/bi9515127 · Cited by 382
De Martino, G., Edler, M. C., La Regina, G., Coluccia, A., Barbera, M. C., Barrow, D., Nicholson, R. I., Chiosis, G., Brancale, A., Hamel, E., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050809s · Cited by 367
Self-citationLindquist, N., Fenical, W., Duyne, G. D. V., & Clardy, J. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00006a060 · Cited by 343
Arylthioindoles, Potent Inhibitors of Tubulin Polymerization
De Martino, G., La Regina, G., Coluccia, A., Edler, M. C., Barbera, M. C., Brancale, A., Wilcox, E., Hamel, E., Artico, M., & Silvestri, R. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049360d · Cited by 294
Self-citationLin, C. M., Singh, S. B., Chu, P. S., Dempcy, R. O., Schmidt, J. M., Pettit, G. R., & Hamel, E. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09364-2 · Cited by 278
Tubulin and microtubule structure
Downing, K. H., & Nogales, E. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80082-3 · Cited by 267
Kingston, D. G. I. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90085-z · Cited by 255
Laulimalides. New potent cytotoxic macrolides from a marine sponge and a nudibranch predator
Corley, D. G., Herb, R., Moore, R. E., Scheuer, P. J., & Paul, V. J. (1988) · The Journal of Organic Chemistry · doi:10.1021/jo00250a053 · Cited by 227
Tryprostatin A, a specific and novel inhibitor of microtubule assembly
USUI, T., KONDOH, M., CUI, C.-B., MAYUMI, T., & OSADA, H. (1998) · Biochemical Journal · doi:10.1042/bj3330543 · Cited by 212
Cragg, G. M., & Newman, D. J. (2004) · Journal of Natural Products · doi:10.1021/np030420c · Cited by 210
A Practical Synthesis of (+)-Discodermolide and Analogues: Fragment Union by Complex Aldol Reactions
Paterson, I., Florence, G. J., Gerlach, K., Scott, J. P., & Sereinig, N. (2001) · Journal of the American Chemical Society · doi:10.1021/ja011211m · Cited by 208
Kuo, C.-C., Hsieh, H.-P., Pan, W.-Y., Chen, C.-P., Liou, J.-P., Lee, S.-J., Chang, Y.-L., Chen, L.-T., Chen, C.-T., & Chang, J.-Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3474 · Cited by 201
Yoshimatsu, K., Yamaguchi, A., Yoshino, H., Koyanagi, N., & Kitoh, K. (1997) · PubMed · Cited by 181
Novel Aspects of Natural and Modified Vinca Alkaloids
Duflos, A., Kruczynski, A., & Barret, J.-M. (2012) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011023354452 · Cited by 166
Shan, B., Medina, J. C., Santha, E., Frankmoelle, W. P., Chou, T.-C., Learned, R. M., Narbut, M. R., Stott, D., Wu, P., Jaen, J. C., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5686 · Cited by 164
Vinflunine, the latest Vinca alkaloid in clinical development
Kruczynski, A., & Hill, B. T. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00183-4 · Cited by 156
Bacher, G., Nickel, B., Emig, P., Vanhoefer, U. J., Seeber, S., Shandra, A., Klenner, T., & Beckers, T. L. (2001) · PubMed · Cited by 142
The synthesis and tubulin binding activity of thiophene-based analogues of combretastatin A-4
Flynn, B. L., Flynn, G. P., Hamel, E., & Jung, M. K. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00436-x · Cited by 140
Li, Q., & Sham, H. L. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.11.1663 · Cited by 133
Recent Progress in the Development of Tubulin Inhibitors As Antimitotic Antitumor Agents
Lee, K., Shi, Q., Chen, K., & Morris-Natschke, S. L. (1970) · Current Pharmaceutical Design · doi:10.2174/138161280403221007124425 · Cited by 105
Synthetic 2-Aroylindole Derivatives as a New Class of Potent Tubulin-Inhibitory, Antimitotic Agents
Mahboobi, S., Pongratz, H., Hufsky, H., Hockemeyer, J., Frieser, M., Lyssenko, A., Paper, D. H., Bürgermeister, J., Böhmer, F., Fiebig, H., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010940+ · Cited by 105
Interactions of combretastatin, a new plant-derived antimitotic agent, with tubulin
Hamel, E., & Lin, C. M. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90163-6 · Cited by 82
Design, Synthesis, and Evaluation of Novel Thienopyrrolizinones as Antitubulin Agents
Lisowski, V., Léonce, S., Kraus‐Berthier, L., Santos, J. S. O., Pierré, A., Atassi, G., Caignard, D., Renard, P., & Rault, S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030961z · Cited by 80
Antimitotic Peptides and Depsipeptides
Hamel, E., & Covell, D. G. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011023354263 · Cited by 70
Yamamoto, K., Noda, K., Yoshimura, A., Fukuoka, M., Furuse, K., & Niitani, H. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050795 · Cited by 64
Recent advances in the field of tubulin polymerization inhibitors
Prinz, H. (2002) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2.6.695 · Cited by 48
Cited by
Martins, P., Jesus, J., Santos, S., Raposo, L., Roma-Rodrigues, C., Baptista, P., & Fernandes, A. (2015) · Molecules · doi:10.3390/molecules200916852 · Cited by 716
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms
Dadashpour, S., & Emami, S. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.065 · Cited by 343
Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review
McLoughlin, E. C., & O’Boyle, N. M. (2020) · Pharmaceuticals · doi:10.3390/ph13010008 · Cited by 316
Metadata
- Authors
- Brancale, A., & Silvestri, R.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2006-06-20
- Volume
- 27
- Issue
- 2
- Pages
- 209-238
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2167864053
- Cited by
- 344
- References
- 31
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.